No painkillers or paracetamol recommended after Covaxin jab: Bharat Biotech

Paracetamol was recommended along with certain other COVID-19 vaccines and is not recommended for Covaxin, it asserted

Bharat Biotech, Covaxin
Photo: Shutterstock
Press Trust of India New Delhi
2 min read Last Updated : Jan 05 2022 | 7:41 PM IST

Bharat Biotech on Wednesday said no painkillers or paracetamol are recommended after being vaccinated with its COVID-19 vaccine Covaxin.

Stating that it has received feedback that certain immunisation centres are recommending taking three paracetamol 500mg tablets along with Covaxin for children, the company clarified that such a step was not required.

"No paracetamol or painkillers are recommended after being vaccinated with Covaxin," Bharat Biotech said in a tweet.

Paracetamol was recommended along with certain other COVID-19 vaccines and is not recommended for Covaxin, it asserted.

"Through our clinical trials spanning 30,000 individuals, approximately 10-20 per cent individuals report side effects. Most of these are mild, resolve within 1-2 days, and do not require medication. Medication is only recommended only after you consult a physician," the company said.

Last month, the Drugs Controller General of India (DCGI) had granted emergency use authorisation to indigenously-developed Bharat Biotech's Covaxin for children above 12 years with certain conditions.

Prime Minister Narendra Modi had announced that vaccination against COVID-19 for children between 15-18 years would start from January 3.

Subsequently, India opened up vaccination for the 15-18 years age-group on Monday and so far over 85 lakh beneficiaries in the category have received the first shot.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jan 05 2022 | 7:41 PM IST

Next Story